Emergent BioSolutions Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Emergent BioSolutions Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Emergent BioSolutions Inc. Depreciation for the quarter ending June 30, 2024 was $12.2M, a 27.4% decline year-over-year.
  • Emergent BioSolutions Inc. Depreciation for the twelve months ending June 30, 2024 was $49M, a 32.6% decline year-over-year.
  • Emergent BioSolutions Inc. annual Depreciation for 2023 was $59.5M, a 28.7% decline from 2022.
  • Emergent BioSolutions Inc. annual Depreciation for 2022 was $83.4M, a 34.1% increase from 2021.
  • Emergent BioSolutions Inc. annual Depreciation for 2021 was $62.2M, a 24.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $59.5M -$23.9M -28.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $83.4M +$21.2M +34.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $62.2M +$12.1M +24.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-08
2020 $50.1M +$600K +1.21% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-12-11
2019 $49.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.